Adrenocortical Carcinoma Treated with o,p'-DDD
نویسندگان
چکیده
منابع مشابه
Cutaneous metastasis in a patient with adrenocortical carcinoma
Adrenocortical carcinoma is an uncommon and aggressivemalignancy. Despite a high frequency of metastasis, cutaneousmetastasis of adrenocortical carcinoma is rare with only isolatedcase reports. Its diagnosis can be challenging based solely onhistopathological findings. Yet, the clinical history in combinationwith an immunohistochemical panel consisting of inhibin,vimentin, chromogranin, synapto...
متن کاملNonfunctional Adrenocortical Carcinoma with Foci of Osseous Metaplasia in a Young Girl
Nonfunctional adrenocortical carcinoma is an extremely rare malignant tumor in children. Unlike the functional tumor which is detected early due to its hormonal presentation, nonfunctional tumor is detected at a later stage. Here we report a case of a 10 year old girl who presented with abdominal mass and symptoms of short duration. No hypertension and cushingoid features were seen. Serum alpha...
متن کاملAn infant with rare adrenocortical carcinoma
Adrenocortical tumors (ACT) include both adrenocortical adenomas (ACA) and adrenocortical carcinomas (ACC). Carcinomas are rare in children and adolescents. In the United States, Surveillance Epidemiology and End Results (SEER) data from the National Cancer Institute show that the proportion of adrenocortical tumors (ACT) in childhood carcinoma is only about 1.3%, and the proportion of ACT in c...
متن کاملFeminizing Adrenocortical Carcinoma with Distinct Histopathological Findings
We herein present a 60-year-old man with adrenocortical carcinoma who had gynecomastia. An endocrinological examination revealed increased levels of serum estradiol and dehydroepiandrosterone-sulfate (DHEA-S) and reduced levels of free testosterone. Magnetic resonance imaging showed an adrenal tumor with heterogeneous intensity. Iodine-131 adosterol scintigraphy showed an increased uptake at th...
متن کاملMitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection.
CONTEXT Mitotane plasma concentrations ≥ 14 mg/l have been shown to predict tumor response and better survival in patients with advanced adrenocortical carcinoma (ACC). A correlation between mitotane concentrations and patient outcome has not been demonstrated in an adjuvant setting. OBJECTIVE To compare recurrence-free survival (RFS) in patients who reached and maintained mitotane concentrat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1965
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.5446.1356